View in EDS PDF Full Text

Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach.

Saved in:
Bibliographic Details
Title: Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach.
Authors: Li V; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, 3010, Australia., McKay FC; Multiple Sclerosis Australia, Suite 3.01 18 Flour Mill Way, Summer Hill, NSW, 2130, Australia. fiona.mckay@msaustralia.org.au., Tscharke DC; Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia., Smith C; Immunology Department, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia., Khanna R; Immunology Department, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia., Lechner-Scott J; University of Newcastle, School of Medicine and Public Health, Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia.; Department of Neurology, John Hunter Hospital, New Lambton Heights, NSW, 2305, Australia., Rawlinson WD; Serology and Virology Division (SAViD), Microbiology NSW Health Pathology, Randwick, NSW, 2031, Australia., Lloyd AR; The Kirby Institute, University of New South Wales, Kensington, NSW, 2052, Australia., Taylor BV; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7000, Australia., Morahan JM; Multiple Sclerosis Australia, Suite 3.01 18 Flour Mill Way, Summer Hill, NSW, 2130, Australia., Steinman L; Departments of Neurology and Neurological Sciences, Stanford University, Stanford, CA, 9305-5101, USA., Giovannoni G; Centre for Neuroscience, Surgery and Trauma, Blizard Institute, Queen Mary University of London, London, E1 2AT, UK., Bar-Or A; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., Levy M; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA., Drosu N; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA., Potter A; Multiple Sclerosis Australia, Suite 3.01 18 Flour Mill Way, Summer Hill, NSW, 2130, Australia., Caswell N; National Advocates, Multiple Sclerosis Australia, Summer Hill, NSW, 2130, Australia., Smith L; National Advocates, Multiple Sclerosis Australia, Summer Hill, NSW, 2130, Australia., Brady EC; National Advocates, Multiple Sclerosis Australia, Summer Hill, NSW, 2130, Australia., Frost B; National Advocates, Multiple Sclerosis Australia, Summer Hill, NSW, 2130, Australia., Hodgkinson S; School of Clinical Medicine, University of New South Wales, Liverpool, NSW, 2170, Australia., Hardy TA; Department of Neurology, Concord Hospital, University of Sydney, Concord West, NSW, 2039, Australia., Broadley SA; School of Medicine and Dentistry, Gold Coast Campus, Griffith University, Southport, QLD, 4222, Australia.; Department of Neurology, Gold Coast University Hospital, Southport, QLD, 4215, Australia.
Corporate Authors: Australian Anti-EBV Drugs for MS Working Group
Source: CNS drugs [CNS Drugs] 2025 Mar; Vol. 39 (3), pp. 305-320. Date of Electronic Publication: 2025 Jan 10.
Publication Type: Journal Article; Systematic Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1934 (Electronic) Linking ISSN: 11727047 NLM ISO Abbreviation: CNS Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39792343
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Li+V%22">Li V</searchLink>; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, 3010, Australia.<br /><searchLink fieldCode="AU" term="%22McKay+FC%22">McKay FC</searchLink>; Multiple Sclerosis Australia, Suite 3.01 18 Flour Mill Way, Summer Hill, NSW, 2130, Australia. fiona.mckay@msaustralia.org.au.<br /><searchLink fieldCode="AU" term="%22Tscharke+DC%22">Tscharke DC</searchLink>; Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia.<br /><searchLink fieldCode="AU" term="%22Smith+C%22">Smith C</searchLink>; Immunology Department, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia.<br /><searchLink fieldCode="AU" term="%22Khanna+R%22">Khanna R</searchLink>; Immunology Department, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia.<br /><searchLink fieldCode="AU" term="%22Lechner-Scott+J%22">Lechner-Scott J</searchLink>; University of Newcastle, School of Medicine and Public Health, Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia.; Department of Neurology, John Hunter Hospital, New Lambton Heights, NSW, 2305, Australia.<br /><searchLink fieldCode="AU" term="%22Rawlinson+WD%22">Rawlinson WD</searchLink>; Serology and Virology Division (SAViD), Microbiology NSW Health Pathology, Randwick, NSW, 2031, Australia.<br /><searchLink fieldCode="AU" term="%22Lloyd+AR%22">Lloyd AR</searchLink>; The Kirby Institute, University of New South Wales, Kensington, NSW, 2052, Australia.<br /><searchLink fieldCode="AU" term="%22Taylor+BV%22">Taylor BV</searchLink>; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7000, Australia.<br /><searchLink fieldCode="AU" term="%22Morahan+JM%22">Morahan JM</searchLink>; Multiple Sclerosis Australia, Suite 3.01 18 Flour Mill Way, Summer Hill, NSW, 2130, Australia.<br /><searchLink fieldCode="AU" term="%22Steinman+L%22">Steinman L</searchLink>; Departments of Neurology and Neurological Sciences, Stanford University, Stanford, CA, 9305-5101, USA.<br /><searchLink fieldCode="AU" term="%22Giovannoni+G%22">Giovannoni G</searchLink>; Centre for Neuroscience, Surgery and Trauma, Blizard Institute, Queen Mary University of London, London, E1 2AT, UK.<br /><searchLink fieldCode="AU" term="%22Bar-Or+A%22">Bar-Or A</searchLink>; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.<br /><searchLink fieldCode="AU" term="%22Levy+M%22">Levy M</searchLink>; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA.<br /><searchLink fieldCode="AU" term="%22Drosu+N%22">Drosu N</searchLink>; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA.<br /><searchLink fieldCode="AU" term="%22Potter+A%22">Potter A</searchLink>; Multiple Sclerosis Australia, Suite 3.01 18 Flour Mill Way, Summer Hill, NSW, 2130, Australia.<br /><searchLink fieldCode="AU" term="%22Caswell+N%22">Caswell N</searchLink>; National Advocates, Multiple Sclerosis Australia, Summer Hill, NSW, 2130, Australia.<br /><searchLink fieldCode="AU" term="%22Smith+L%22">Smith L</searchLink>; National Advocates, Multiple Sclerosis Australia, Summer Hill, NSW, 2130, Australia.<br /><searchLink fieldCode="AU" term="%22Brady+EC%22">Brady EC</searchLink>; National Advocates, Multiple Sclerosis Australia, Summer Hill, NSW, 2130, Australia.<br /><searchLink fieldCode="AU" term="%22Frost+B%22">Frost B</searchLink>; National Advocates, Multiple Sclerosis Australia, Summer Hill, NSW, 2130, Australia.<br /><searchLink fieldCode="AU" term="%22Hodgkinson+S%22">Hodgkinson S</searchLink>; School of Clinical Medicine, University of New South Wales, Liverpool, NSW, 2170, Australia.<br /><searchLink fieldCode="AU" term="%22Hardy+TA%22">Hardy TA</searchLink>; Department of Neurology, Concord Hospital, University of Sydney, Concord West, NSW, 2039, Australia.<br /><searchLink fieldCode="AU" term="%22Broadley+SA%22">Broadley SA</searchLink>; School of Medicine and Dentistry, Gold Coast Campus, Griffith University, Southport, QLD, 4222, Australia.; Department of Neurology, Gold Coast University Hospital, Southport, QLD, 4215, Australia.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Australian+Anti-EBV+Drugs+for+MS+Working+Group%22">Australian Anti-EBV Drugs for MS Working Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229431220%22">CNS drugs</searchLink> [CNS Drugs] 2025 Mar; Vol. 39 (3), pp. 305-320. <i>Date of Electronic Publication: </i>2025 Jan 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Systematic Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9431220 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1934 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211727047%22">11727047 </searchLink><i>NLM ISO Abbreviation: </i>CNS Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39792343
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40263-024-01153-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 305
    Titles:
      – TitleFull: Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Li V
      – PersonEntity:
          Name:
            NameFull: McKay FC
      – PersonEntity:
          Name:
            NameFull: Tscharke DC
      – PersonEntity:
          Name:
            NameFull: Smith C
      – PersonEntity:
          Name:
            NameFull: Khanna R
      – PersonEntity:
          Name:
            NameFull: Lechner-Scott J
      – PersonEntity:
          Name:
            NameFull: Rawlinson WD
      – PersonEntity:
          Name:
            NameFull: Lloyd AR
      – PersonEntity:
          Name:
            NameFull: Taylor BV
      – PersonEntity:
          Name:
            NameFull: Morahan JM
      – PersonEntity:
          Name:
            NameFull: Steinman L
      – PersonEntity:
          Name:
            NameFull: Giovannoni G
      – PersonEntity:
          Name:
            NameFull: Bar-Or A
      – PersonEntity:
          Name:
            NameFull: Levy M
      – PersonEntity:
          Name:
            NameFull: Drosu N
      – PersonEntity:
          Name:
            NameFull: Potter A
      – PersonEntity:
          Name:
            NameFull: Caswell N
      – PersonEntity:
          Name:
            NameFull: Smith L
      – PersonEntity:
          Name:
            NameFull: Brady EC
      – PersonEntity:
          Name:
            NameFull: Frost B
      – PersonEntity:
          Name:
            NameFull: Hodgkinson S
      – PersonEntity:
          Name:
            NameFull: Hardy TA
      – PersonEntity:
          Name:
            NameFull: Broadley SA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2025 Mar
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1934
          Numbering:
            – Type: volume
              Value: 39
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: CNS drugs
              Type: main
ResultId 1